ACT 335827

CAS : 1354039-86-3

Ref. 3D-EEC03986

Informations sur le produit

• Nom: ACT 335827

Description

ACT 335827 is a drug that is effective in the treatment of hypertension. It has a pyrazole ring, which is metabolized to form fatty acids, and it targets the pressor pathway by inhibiting phosphodiesterase-3. ACT 335827 also interacts with the template molecule, hydrogen bond, and constant region of the protein. The pharmacological effects are mediated through pharmacological agents that alter physiological processes. Almorexant is one such agent, which inhibits orexin receptors in the brain to induce sleepiness.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 518.64 g/mol
• Formule: C₃₁H₃₈N₂O₅
• Degré de pureté: Min. 95%